Literature DB >> 25444863

Knockout of leucine aminopeptidase in Toxoplasma gondii using CRISPR/Cas9.

Jun Zheng1, Honglin Jia2, Yonghui Zheng1.   

Abstract

Leucine aminopeptidases of the M17 peptidase family represent ideal drug targets for therapies directed against the pathogens Plasmodium, Babesia and Trypanosoma. Previously, we characterised Toxoplasma gondii leucine aminopeptidase and demonstrated its role in regulating the levels of free amino acids. In this study, we evaluated the potential of T. gondii leucine aminopeptidase as a drug target in T. gondii by a knockout method. Existing knockout methods for T. gondii have many drawbacks; therefore, we developed a new technique that takes advantage of the CRISPR/Cas9 system. We first chose a Cas9 target site in the gene encoding T. gondii leucine aminopeptidase and then constructed a knockout vector containing Cas9 and the single guide RNA. After transfection, single tachyzoites were cloned in 96-well plates by limiting dilution. Two transfected strains derived from a single clone were cultured in Vero cells, and then subjected to expression analysis by western blotting. The phenotypic analysis revealed that knockout of T. gondii leucine aminopeptidase resulted in inhibition of attachment/invasion and replication; both the growth and attachment/invasion capacity of knockout parasites were restored by complementation with a synonymously substituted allele of T. gondii leucine aminopeptidase. Mouse experiments demonstrated that T. gondii leucine aminopeptidase knockout somewhat reduced the pathogenicity of T. gondii. An enzymatic activity assay showed that T. gondii leucine aminopeptidase knockout reduced the processing of a leucine aminopeptidase-specific substrate in T. gondii. The absence of leucine aminopeptidase activity could be slightly compensated for in T. gondii. Overall, T. gondii leucine aminopeptidase knockout influenced the growth of T. gondii, but did not completely block parasite development, virulence or enzymatic activity. Therefore, we conclude that leucine aminopeptidase would be useful only as an adjunctive drug target in T. gondii.
Copyright © 2014 Australian Society for Parasitology Inc. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  CRISP/Cas9; Growth; Invasion; Leucine aminopeptidase; Toxoplasma gondii

Mesh:

Substances:

Year:  2014        PMID: 25444863     DOI: 10.1016/j.ijpara.2014.09.003

Source DB:  PubMed          Journal:  Int J Parasitol        ISSN: 0020-7519            Impact factor:   3.981


  19 in total

1.  Genetic and chemical validation of Plasmodium falciparum aminopeptidase PfA-M17 as a drug target in the hemoglobin digestion pathway.

Authors:  Rebecca C S Edgar; Ghizal Siddiqui; Katheryn Hjerrild; Tess R Malcolm; Natalie B Vinh; Chaille T Webb; Clare Holmes; Christopher A MacRaild; Hope C Chernih; Willy W Suen; Natalie A Counihan; Darren J Creek; Peter J Scammells; Sheena McGowan; Tania F de Koning-Ward
Journal:  Elife       Date:  2022-09-13       Impact factor: 8.713

2.  Hydroxylamine and Carboxymethoxylamine Can Inhibit Toxoplasma gondii Growth through an Aspartate Aminotransferase-Independent Pathway.

Authors:  Jixu Li; Huanping Guo; Eloiza May Galon; Yang Gao; Seung-Hun Lee; Mingming Liu; Yongchang Li; Shengwei Ji; Honglin Jia; Xuenan Xuan
Journal:  Antimicrob Agents Chemother       Date:  2020-02-21       Impact factor: 5.191

Review 3.  Genome Editing by CRISPR/Cas9: A Game Change in the Genetic Manipulation of Protists.

Authors:  Noelia Lander; Miguel A Chiurillo; Roberto Docampo
Journal:  J Eukaryot Microbiol       Date:  2016-07-15       Impact factor: 3.346

4.  Structural Characterization of Acidic M17 Leucine Aminopeptidases from the TriTryps and Evaluation of Their Role in Nutrient Starvation in Trypanosoma brucei.

Authors:  Jennifer Timm; Maria Valente; Daniel García-Caballero; Keith S Wilson; Dolores González-Pacanowska
Journal:  mSphere       Date:  2017-08-16       Impact factor: 4.389

5.  The heat shock protein 90 of Toxoplasma gondii is essential for invasion of host cells and tachyzoite growth.

Authors:  Hongchao Sun; Xunhui Zhuo; Xianfeng Zhao; Yi Yang; Xueqiu Chen; Chaoqun Yao; Aifang Du
Journal:  Parasite       Date:  2017-06-19       Impact factor: 3.000

6.  Characterization of aspartyl aminopeptidase from Toxoplasma gondii.

Authors:  Jun Zheng; Ziying Cheng; Honglin Jia; Yonghui Zheng
Journal:  Sci Rep       Date:  2016-09-28       Impact factor: 4.379

7.  EuPaGDT: a web tool tailored to design CRISPR guide RNAs for eukaryotic pathogens.

Authors:  Duo Peng; Rick Tarleton
Journal:  Microb Genom       Date:  2015-10-30

8.  Excision of Nucleopolyhedrovirus Form Transgenic Silkworm Using the CRISPR/Cas9 System.

Authors:  Zhanqi Dong; Feifan Dong; Xinbo Yu; Liang Huang; Yaming Jiang; Zhigang Hu; Peng Chen; Cheng Lu; Minhui Pan
Journal:  Front Microbiol       Date:  2018-02-16       Impact factor: 5.640

9.  CCL24 Protects Renal Function by Controlling Inflammation in Podocytes.

Authors:  Youdi Wang; Xue Wu; Mengya Geng; Jiamin Ding; Kangjia Lv; Hui Du; Jiahui Ding; Wenjun Pei; Xin Hu; Jing Gu; Lizhuo Wang; Yao Zhang; Jialin Gao
Journal:  Dis Markers       Date:  2021-06-16       Impact factor: 3.434

Review 10.  Synthetic biology for pharmaceutical drug discovery.

Authors:  Jean-Yves Trosset; Pablo Carbonell
Journal:  Drug Des Devel Ther       Date:  2015-12-03       Impact factor: 4.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.